vTv Therapeutics Inc. Balance Sheet
VTVT|11 years of annual SEC 10-K data (FY2015-FY2025)
Shows total assets, cash and equivalents, receivables, property and equipment, total debt, and shareholders' equity across 11 fiscal years. All figures from audited SEC 10-K filings.
vTv Therapeutics Inc. had $90M in total assets and $64M in shareholders' equity as of FY2025.
Based on SEC 10-K filings.
Key Data Points
- Altman Z-Score 0.85 (distress zone, below 1.8 threshold)
Data sourced from SEC EDGAR filings. Not investment advice.
| Item | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 | FY2017 | FY2016 | FY2015 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash & Equivalents | $88.9M | $36.7M | $9.4M | $12.1M | $13.4M | $5.7M | $1.8M | $1.7M | $11.8M | $88.0M | $1.1M |
| Accounts Receivable | - | - | $102.0K | $173.0K | $57.0K | $158.0K | $5.0K | - | $0 | $0 | $69.0K |
| Current Assets | $89.9M | $38.1M | $10.7M | $27.1M | $15.6M | $7.2M | $2.8M | $3.5M | $20.4M | $52.1M | $89.2M |
| PP&E (Net) | - | $28.0K | $117.0K | $207.0K | $278.0K | $367.0K | $461.0K | $70.0K | $283.0K | $444.0K | $624.0K |
| Total Assets | $89.9M | $38.3M | $11.0M | $33.2M | $25.5M | $14.8M | $9.3M | $8.6M | $27.9M | $54.5M | $91.5M |
| Current Liabilities | $6.6M | $5.2M | $10.6M | $7.7M | $8.5M | $6.4M | $13.4M | $18.8M | $26.9M | $11.4M | $7.7M |
| Shareholders' Equity | $64.4M | $12.2M | -$24.7M | -$80.1M | -$49.0M | -$82.9M | -$151.0M | -$90.9M | -$78.0M | -$498.8M | -$303.7M |